These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 3498523)
1. The von willebrand factor domain-mediating botrocetin-induced binding to glycoprotein IB lies between Val449 and Lys728. Fujimura Y; Holland LZ; Ruggeri ZM; Zimmerman TS Blood; 1987 Oct; 70(4):985-8. PubMed ID: 3498523 [TBL] [Abstract][Full Text] [Related]
2. Enhanced botrocetin-induced type IIB von Willebrand factor binding to platelet glycoprotein Ib initiates hyperagglutination of normal platelets. Nishio K; Fujimura Y; Niinomi K; Takahashi Y; Yoshioka A; Fukui H; Usami Y; Titani K; Ruggeri ZM; Zimmerman TS Am J Hematol; 1990 Apr; 33(4):261-6. PubMed ID: 2316510 [TBL] [Abstract][Full Text] [Related]
3. Identification of amino acid residues essential for von Willebrand factor binding to platelet glycoprotein Ib. Charged-to-alanine scanning mutagenesis of the A1 domain of human von Willebrand factor. Matsushita T; Sadler JE J Biol Chem; 1995 Jun; 270(22):13406-14. PubMed ID: 7539426 [TBL] [Abstract][Full Text] [Related]
4. Purification of botrocetin from Bothrops jararaca venom. Analysis of the botrocetin-mediated interaction between von Willebrand factor and the human platelet membrane glycoprotein Ib-IX complex. Andrews RK; Booth WJ; Gorman JJ; Castaldi PA; Berndt MC Biochemistry; 1989 Oct; 28(21):8317-26. PubMed ID: 2557900 [TBL] [Abstract][Full Text] [Related]
5. Mutant botrocetin-2 inhibits von Willebrand factor-induced platelet agglutination. Matsui T; Hori A; Hamako J; Matsushita F; Ozeki Y; Sakurai Y; Hayakawa M; Matsumoto M; Fujimura Y J Thromb Haemost; 2017 Mar; 15(3):538-548. PubMed ID: 28071872 [TBL] [Abstract][Full Text] [Related]
6. Ristocetin and botrocetin involve two distinct domains of von Willebrand factor for binding to platelet membrane glycoprotein Ib. Girma JP; Takahashi Y; Yoshioka A; Diaz J; Meyer D Thromb Haemost; 1990 Oct; 64(2):326-32. PubMed ID: 1702906 [TBL] [Abstract][Full Text] [Related]
7. Structure and function of the von Willebrand factor A1 domain: analysis with monoclonal antibodies reveals distinct binding sites involved in recognition of the platelet membrane glycoprotein Ib-IX-V complex and ristocetin-dependent activation. De Luca M; Facey DA; Favaloro EJ; Hertzberg MS; Whisstock JC; McNally T; Andrews RK; Berndt MC Blood; 2000 Jan; 95(1):164-72. PubMed ID: 10607699 [TBL] [Abstract][Full Text] [Related]
8. Identification of aspartic acid 514 through glutamic acid 542 as a glycoprotein Ib-IX complex receptor recognition sequence in von Willebrand factor. Mechanism of modulation of von Willebrand factor by ristocetin and botrocetin. Berndt MC; Ward CM; Booth WJ; Castaldi PA; Mazurov AV; Andrews RK Biochemistry; 1992 Nov; 31(45):11144-51. PubMed ID: 1359905 [TBL] [Abstract][Full Text] [Related]
9. Studies on anti-von Willebrand factor (vWF) monoclonal antibody NMC-4, which inhibits both ristocetin- and botrocetin-induced vWF binding to platelet glycoprotein Ib. Fujimura Y; Usami Y; Titani K; Niinomi K; Nishio K; Takase T; Yoshioka A; Fukui H Blood; 1991 Jan; 77(1):113-20. PubMed ID: 1984791 [TBL] [Abstract][Full Text] [Related]
10. Identification of a site in the alpha chain of platelet glycoprotein Ib that participates in von Willebrand factor binding. Vicente V; Houghten RA; Ruggeri ZM J Biol Chem; 1990 Jan; 265(1):274-80. PubMed ID: 2104618 [TBL] [Abstract][Full Text] [Related]
11. Type 2M von Willebrand disease: F606I and I662F mutations in the glycoprotein Ib binding domain selectively impair ristocetin- but not botrocetin-mediated binding of von Willebrand factor to platelets. Hillery CA; Mancuso DJ; Evan Sadler J; Ponder JW; Jozwiak MA; Christopherson PA; Cox Gill J; Paul Scott J; Montgomery RR Blood; 1998 Mar; 91(5):1572-81. PubMed ID: 9473222 [TBL] [Abstract][Full Text] [Related]
12. von Willebrand disease type B: a missense mutation selectively abolishes ristocetin-induced von Willebrand factor binding to platelet glycoprotein Ib. Rabinowitz I; Tuley EA; Mancuso DJ; Randi AM; Firkin BG; Howard MA; Sadler JE Proc Natl Acad Sci U S A; 1992 Oct; 89(20):9846-9. PubMed ID: 1409710 [TBL] [Abstract][Full Text] [Related]
13. Mocarhagin, a novel cobra venom metalloproteinase, cleaves the platelet von Willebrand factor receptor glycoprotein Ibalpha. Identification of the sulfated tyrosine/anionic sequence Tyr-276-Glu-282 of glycoprotein Ibalpha as a binding site for von Willebrand factor and alpha-thrombin. Ward CM; Andrews RK; Smith AI; Berndt MC Biochemistry; 1996 Apr; 35(15):4929-38. PubMed ID: 8664285 [TBL] [Abstract][Full Text] [Related]
14. Identification of discontinuous von Willebrand factor sequences involved in complex formation with botrocetin. A model for the regulation of von Willebrand factor binding to platelet glycoprotein Ib. Sugimoto M; Mohri H; McClintock RA; Ruggeri ZM J Biol Chem; 1991 Sep; 266(27):18172-8. PubMed ID: 1917949 [TBL] [Abstract][Full Text] [Related]
15. Binding site on human von Willebrand factor of bitiscetin, a snake venom-derived platelet aggregation inducer. Matsui T; Hamako J; Matsushita T; Nakayama T; Fujimura Y; Titani K Biochemistry; 2002 Jun; 41(25):7939-46. PubMed ID: 12069583 [TBL] [Abstract][Full Text] [Related]
16. Conformational changes in the A3 domain of von Willebrand factor modulate the interaction of the A1 domain with platelet glycoprotein Ib. Obert B; Houllier A; Meyer D; Girma JP Blood; 1999 Mar; 93(6):1959-68. PubMed ID: 10068669 [TBL] [Abstract][Full Text] [Related]
17. von Willebrand factor mediates platelet spreading through glycoprotein Ib and alpha(IIb)beta3 in the presence of botrocetin and ristocetin, respectively. McCarty OJ; Calaminus SD; Berndt MC; Machesky LM; Watson SP J Thromb Haemost; 2006 Jun; 4(6):1367-78. PubMed ID: 16706984 [TBL] [Abstract][Full Text] [Related]
18. Antiplatelet glycoprotein Ib monoclonal antibody (OP-F1) totally abolishes ristocetin-induced von Willebrand factor binding, but has minimal effect on the botrocetin-induced binding. Nishio K; Fujimura Y; Nishida S; Takeda I; Yoshioka A; Fukui H; Tomiyama Y; Kurata Y Haemostasis; 1991; 21(6):353-9. PubMed ID: 1823880 [TBL] [Abstract][Full Text] [Related]
19. Aurin tricarboxylic acid inhibits platelet adhesion to collagen by binding to the 509-695 disulphide loop of von Willebrand factor and competing with glycoprotein Ib. Girma JP; Fressinaud E; Christophe O; Rouault C; Obert B; Takahashi Y; Meyer D Thromb Haemost; 1992 Dec; 68(6):707-13. PubMed ID: 1287886 [TBL] [Abstract][Full Text] [Related]
20. A new mutation, S1285F, within the A1 loop of von Willebrand factor induces a conformational change in A1 loop with abnormal binding to platelet GPIb and botrocetin causing type 2M von Willebrand disease. Stepanian A; Ribba AS; Lavergne JM; Fressinaud E; Juhan-Vague I; Mazurier C; Girma JP; Meyer D Br J Haematol; 2003 Feb; 120(4):643-51. PubMed ID: 12588351 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]